Laddar...
Development of a palivizumab specialty pharmacy management program
Background: Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high risk pediatric patients. Due to the high cost, handling requirements, administration route, and importance of adherence, palivizumab is best managed...
Sparad:
| I publikationen: | J Drug Assess |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764365/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658299 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|